© Reuters. FILE PHOTO: Britain’s Prince Charles and AstraZeneca Chairman Leif Johansson smile throughout a go to on the AstraZeneca international R&D facility on the Cambridge Biomedical Campus in Cambridge, Britain November 23, 2021. Chris Jackson/Pool by way of REUTERS
(Reuters) -AstraZeneca mentioned on Tuesday its non-executive chairman Leif Johansson would retire subsequent 12 months following the Anglo-Swedish drugmaker’s annual basic assembly, after having served 11 years within the position.
The Swedish businessman, 70, grew to become chairman in 2012, across the identical time Chief Government Officer Pascal Soriot took cost. Soriot in an interview with the Monetary Occasions final Might indicated that succession planning had begun for him and Johansson.
The corporate mentioned on Tuesday the seek for a chair successor was “continuing nicely.”
Final 12 months, AstraZeneca (NASDAQ:) had requested Johansson to proceed within the position to supervise its now-completed $39 billion acquisition of uncommon illnesses medicines maker Alexion (NASDAQ:).
“The Board believes it might be in one of the best pursuits of shareholders for Mr Johansson to hunt re-election on the AGM in April 2022 and proceed to function Chair for one additional 12 months,” AstraZeneca mentioned in an announcement.
Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or injury on account of reliance on the knowledge together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be absolutely knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding kinds potential.
Leave a Reply